×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

  • Gurus
  • Other
  • VIVO CAPITAL, LLC (Data extracted from 13F, 13D, 13G and Form 4)

VIVO CAPITAL, LLC

AUM: $5.81 B
13-F Portfolio Value: $1.10 B
Last 13-F Filed: Q2 2026
Concentration in top 10: 52.41%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
COGTCogent Biosciences Inc-422,300Exited13F
CMPSCompass Pathway PLC-200,000Exited13F
SLNOSoleno Therapeutics Inc-294,909Exited13F
TERNTerns Pharmaceuticals Inc-1,334,418Exited13F
MANEVeradermics Inc-300,000Exited13F
VRDNViridian Therapeutics Inc-166,288Exited13F